Research Labs

Dellaripa Lab

Dr. Dellaripa’s interest and expertise are in interstitial lung disease as it relates to autoimmune diseases including rheumatoid arthritis (RA), lupus scleroderma, myositis and sarcoidosis.

Dr. El-Chemaly’s clinical interest is in interstitial lung disease and lung transplant. He spends his clinical time attending on the in-patient lung transplant service. In addition, Dr. El-Chemaly is an active member of the ILD/lymphangioleiomyomatosis (LAM) team, attending in clinic and actively participating in clinical trials at Brigham and Women's Hospital.

Goldberg Lab

Dr. Goldberg is the Co-director of the ILD Clinic and Medical Director of the BWH Lung Transplant Program at Brigham and Women’s Hospital. Her research focus is in clinical trial design and implementation within the LAM, ILD, and transplant programs at BWH.

Hunninghake Lab

Dr. Hunninghake’s clinical and research interests include identifying epidemiologic and genetic risk factors for interstitial lung disease.

Morse Lab

Dr. Morse’s laboratory focuses on identifying the mechanism by which carbon monoxide, a naturally occurring product of cells, can alter the progression of fibrosis.

Rosas Lab

Dr. Rosas’ research group has a long-standing clinical research interest in the natural history of early pulmonary fibrosis in susceptible cohorts, has extensively phenotyped patients affected with sporadic idiopathic pulmonary fibrosis, kindred’s affected with familial pulmonary fibrosis, and patients with rheumatoid arthritis affected with secondary pulmonary fibrosis.

Tager Lab

Dr. Tager's research interestes are in identifying new important pathways in the development of idiopathic pulmonary fibrosis that could become additional therapeutic targets.